Bridging the Gap Between Participants and Clinical Trials


Find Clinical Trials

Generic filters
Search for
Clinical Trials

Get involved in local research! aims to connect individuals with relevant clinical trials.

Clinical trials are scientific studies usually testing new treatments, and are available for either healthy volunteers or individuals with specific illnesses. In the long run, your contribution gives hope for safe and effective treatments.


Get notified of future clinical trials

You can receive email notifications about new clinical trials as they are posted. Join our community to be informed of the studies that are relevant to you!

Frequently Asked Questions

Latest Clinical Trials


CheckMate-901 is a phase 3 open-label clinical research study of drugs named nivolumab and ipilimumab. This study will test these drugs in adults with cancer of the bladder or upper urinary tract (also called urothelial cancer, or UC). The primary purpose of this study is to test a combination of nivolumab and ipilimumab for UC.…

Read More


This is an open-label Phase 1/2 study to assess the safety and tolerability of combination PD-1 inhibitor (nivolumab) administered concomitantly with c-Met inhibitor (APL-101), to determine the recommended Phase 2 dose of the combination, and to obtain preliminary efficacy in subjects with advanced or metastatic Renal Cell Carcinoma that have not been previously treated with…

Read More


POLARIS is a Phase 2 research trial testing a potential new treatment for BRAFV600-mutant positive melanoma that has spread to the brain. The new treatment is called encorafenib (Braftovi) + binimetinib (Mektovi). The purpose of this research trial is to determine if high‑dose encorafenib and binimetinib versus standard-dose encorafenib and binimetinib are safe and effective…

Read More


This is a Phase III, randomized, double-blind, placebo-controlled, multi-center, global study to assess the efficacy and safety of durvalumab in combination with bevacizumab or durvalumab monotherapy or placebo as adjuvant therapy. This study will be conducted in patients with HCC who are at high risk of recurrence after curative hepatic resection or ablation.

Read More